(-)-demecolcine decreases expression ISO RGD:1604164 6480464 Demecolcine results in decreased expression of ANKRD37 mRNA CTD PMID:23649840 1,10-phenanthroline increases expression ISO RGD:1604164 6480464 1, 10-phenanthroline results in increased expression of ANKRD37 mRNA CTD PMID:19502547 1,2-dichloroethane decreases expression ISO RGD:1616237 6480464 ethylene dichloride results in decreased expression of ANKRD37 mRNA CTD PMID:28960355 1,2-dimethylhydrazine decreases expression ISO RGD:1616237 6480464 1, 2-Dimethylhydrazine results in decreased expression of ANKRD37 mRNA CTD PMID:22206623 1-chloro-2,4-dinitrobenzene increases expression ISO RGD:1604164 6480464 Dinitrochlorobenzene results in increased expression of ANKRD37 mRNA CTD PMID:25236440 17beta-estradiol decreases expression ISO RGD:1604164 6480464 Estradiol results in decreased expression of ANKRD37 mRNA CTD PMID:21632981 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:1604164 6480464 Dihydrotestosterone results in increased expression of ANKRD37 mRNA CTD PMID:29581250 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1616237 6480464 Tetrachlorodibenzodioxin affects the expression of ANKRD37 mRNA CTD PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of ANKRD37 mRNA CTD PMID:33387578 2,4-diaminotoluene decreases expression ISO RGD:1616237 6480464 2, 4-diaminotoluene results in decreased expression of ANKRD37 mRNA CTD PMID:20713471 2-hydroxypropanoic acid decreases expression ISO RGD:1604164 6480464 Lactic Acid results in decreased expression of ANKRD37 mRNA CTD PMID:30851411 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1604164 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of ANKRD37 mRNA CTD PMID:28628672 4-hydroxyphenyl retinamide increases expression ISO RGD:1616237 6480464 Fenretinide results in increased expression of ANKRD37 mRNA CTD PMID:28973697 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of ANKRD37 mRNA CTD PMID:24780913 acrylamide increases expression ISO RGD:1616237 6480464 Acrylamide results in increased expression of ANKRD37 mRNA CTD PMID:30807115 aflatoxin B1 decreases expression ISO RGD:1616237 6480464 Aflatoxin B1 results in decreased expression of ANKRD37 mRNA CTD PMID:19770486 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of ANKRD37 mRNA CTD PMID:30779732 arsane multiple interactions ISO RGD:1604164 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of ANKRD37 mRNA CTD PMID:32525701 arsenic atom multiple interactions ISO RGD:1604164 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of ANKRD37 mRNA CTD PMID:32525701 arsenite(3-) increases methylation ISO RGD:1604164 6480464 arsenite results in increased methylation of ANKRD37 promoter CTD PMID:23974009 atrazine increases expression ISO RGD:1604164 6480464 Atrazine results in increased expression of ANKRD37 mRNA CTD PMID:22378314 benzo[a]pyrene decreases expression ISO RGD:1616237 6480464 Benzo(a)pyrene results in decreased expression of ANKRD37 mRNA CTD PMID:20713471 benzo[a]pyrene affects methylation ISO RGD:1604164 6480464 Benzo(a)pyrene affects the methylation of ANKRD37 promoter CTD PMID:27901495 benzo[a]pyrene multiple interactions ISO RGD:1616237 6480464 AHR protein affects the reaction [Benzo(a)pyrene affects the expression of ANKRD37 mRNA] CTD PMID:22228805 benzo[a]pyrene diol epoxide I increases expression ISO RGD:1604164 6480464 7 more ... CTD PMID:19150397 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ANKRD37 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:1616237 6480464 bisphenol A results in decreased expression of ANKRD37 mRNA CTD PMID:35479511 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ANKRD37 mRNA CTD PMID:34947998 bisphenol A affects expression ISO RGD:1604164 6480464 bisphenol A affects the expression of ANKRD37 mRNA CTD PMID:30903817 bisphenol A increases expression ISO RGD:1616237 6480464 bisphenol A results in increased expression of ANKRD37 mRNA CTD PMID:25594700 caffeine decreases expression EXP 6480464 Caffeine results in decreased expression of ANKRD37 mRNA CTD PMID:20864626 calcitriol increases expression ISO RGD:1604164 6480464 Calcitriol results in increased expression of ANKRD37 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:1604164 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of ANKRD37 mRNA CTD PMID:21592394 carbon nanotube decreases expression ISO RGD:1616237 6480464 Nanotubes, Carbon results in decreased expression of ANKRD37 mRNA CTD PMID:25620056 carbon nanotube increases expression ISO RGD:1616237 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 CGP 52608 multiple interactions ISO RGD:1604164 6480464 CGP 52608 promotes the reaction [RORA protein binds to ANKRD37 gene] CTD PMID:28238834 chloroprene decreases expression ISO RGD:1616237 6480464 Chloroprene results in decreased expression of ANKRD37 mRNA CTD PMID:23125180 clothianidin decreases expression ISO RGD:1604164 6480464 clothianidin results in decreased expression of ANKRD37 mRNA CTD PMID:31626844 cobalt dichloride multiple interactions ISO RGD:1604164 6480464 zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of ANKRD37 mRNA] CTD PMID:22202117 cobalt dichloride increases expression ISO RGD:1604164 6480464 cobaltous chloride results in increased expression of ANKRD37 mRNA CTD PMID:19502547 , PMID:22202117 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of ANKRD37 mRNA CTD PMID:23814049 , PMID:24386269 cobalt(2+) sulfate increases expression ISO RGD:1604164 6480464 cobalt sulfate results in increased expression of ANKRD37 mRNA CTD PMID:19502547 copper atom multiple interactions ISO RGD:1604164 6480464 [NSC 689534 binds to Copper] which results in increased expression of ANKRD37 mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:1604164 6480464 [NSC 689534 binds to Copper] which results in increased expression of ANKRD37 mRNA CTD PMID:20971185 coumarin 460 increases expression ISO RGD:1604164 6480464 4-methyl-7-diethylaminocoumarin results in increased expression of ANKRD37 mRNA CTD PMID:19502547 crotonaldehyde increases expression ISO RGD:1604164 6480464 2-butenal results in increased expression of ANKRD37 mRNA CTD PMID:20471460 curcumin decreases expression ISO RGD:1604164 6480464 Curcumin results in decreased expression of ANKRD37 mRNA CTD PMID:17198877 cyclosporin A affects expression ISO RGD:1604164 6480464 Cyclosporine affects the expression of ANKRD37 mRNA CTD PMID:20106945 cyclosporin A increases expression ISO RGD:1604164 6480464 Cyclosporine results in increased expression of ANKRD37 mRNA CTD PMID:27989131 cyclosporin A decreases expression ISO RGD:1604164 6480464 Cyclosporine results in decreased expression of ANKRD37 mRNA CTD PMID:21632981 , PMID:25562108 cyclosporin A decreases expression ISO RGD:1616237 6480464 Cyclosporine results in decreased expression of ANKRD37 mRNA CTD PMID:19770486 deoxynivalenol decreases expression ISO RGD:1604164 6480464 deoxynivalenol results in decreased expression of ANKRD37 mRNA CTD PMID:31863870 dexamethasone multiple interactions ISO RGD:1604164 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of ANKRD37 mRNA CTD PMID:28628672 dibutyl phthalate decreases expression ISO RGD:1616237 6480464 Dibutyl Phthalate results in decreased expression of ANKRD37 mRNA CTD PMID:21266533 dioxygen increases expression ISO RGD:1616237 6480464 Oxygen deficiency results in increased expression of ANKRD37 mRNA CTD PMID:20880076 dioxygen multiple interactions ISO RGD:1616237 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ANKRD37 mRNA CTD PMID:30529165 dioxygen increases expression ISO RGD:1604164 6480464 Oxygen deficiency results in increased expression of ANKRD37 mRNA CTD PMID:19502547 more ... dioxygen multiple interactions ISO RGD:1604164 6480464 1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1 more ... CTD PMID:24403227 diphenylcyclopropenone increases expression ISO RGD:1604164 6480464 diphenylcyclopropenone results in increased expression of ANKRD37 mRNA CTD PMID:25236440 dorsomorphin multiple interactions ISO RGD:1604164 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 endosulfan affects expression EXP 6480464 Endosulfan affects the expression of ANKRD37 mRNA CTD PMID:29391264 entinostat decreases expression ISO RGD:1604164 6480464 entinostat results in decreased expression of ANKRD37 mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:1604164 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ANKRD37 mRNA CTD PMID:27188386 ethyl methanesulfonate decreases expression ISO RGD:1604164 6480464 Ethyl Methanesulfonate results in decreased expression of ANKRD37 mRNA CTD PMID:23649840 fluoranthene multiple interactions ISO RGD:1616237 6480464 [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ANKRD37 mRNA CTD PMID:28329830 formaldehyde increases expression ISO RGD:1604164 6480464 Formaldehyde results in increased expression of ANKRD37 mRNA CTD PMID:20655997 , PMID:23416264 formaldehyde decreases expression ISO RGD:1604164 6480464 Formaldehyde results in decreased expression of ANKRD37 mRNA CTD PMID:23649840 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of ANKRD37 mRNA CTD PMID:21396975 indometacin multiple interactions ISO RGD:1604164 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of ANKRD37 mRNA CTD PMID:28628672 iron atom increases expression EXP 6480464 Iron deficiency results in increased expression of ANKRD37 mRNA CTD PMID:16629162 iron atom increases expression ISO RGD:1616237 6480464 Iron deficiency results in increased expression of ANKRD37 mRNA CTD PMID:23776592 iron(0) increases expression ISO RGD:1616237 6480464 Iron deficiency results in increased expression of ANKRD37 mRNA CTD PMID:23776592 iron(0) increases expression EXP 6480464 Iron deficiency results in increased expression of ANKRD37 mRNA CTD PMID:16629162 leflunomide decreases expression ISO RGD:1604164 6480464 leflunomide results in decreased expression of ANKRD37 mRNA CTD PMID:28988120 lipopolysaccharide increases expression ISO RGD:1604164 6480464 Lipopolysaccharides results in increased expression of ANKRD37 mRNA CTD PMID:35811015 lipopolysaccharide multiple interactions ISO RGD:1604164 6480464 [S-(1 more ... CTD PMID:35811015 menadione decreases expression ISO RGD:1616237 6480464 Vitamin K 3 results in decreased expression of ANKRD37 mRNA CTD PMID:25270620 methoxyacetic acid decreases expression EXP 6480464 methoxyacetic acid results in decreased expression of ANKRD37 mRNA CTD PMID:20864626 methyl methanesulfonate decreases expression ISO RGD:1604164 6480464 Methyl Methanesulfonate results in decreased expression of ANKRD37 mRNA CTD PMID:23649840 methylmercury chloride decreases expression EXP 6480464 methylmercuric chloride results in decreased expression of ANKRD37 mRNA CTD PMID:20864626 methylmercury chloride decreases expression ISO RGD:1604164 6480464 methylmercuric chloride results in decreased expression of ANKRD37 mRNA CTD PMID:23179753 , PMID:27188386 mithramycin decreases expression EXP 6480464 Plicamycin results in decreased expression of ANKRD37 mRNA CTD PMID:23814049 Monobutylphthalate decreases expression EXP 6480464 monobutyl phthalate results in decreased expression of ANKRD37 mRNA CTD PMID:20864626 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of ANKRD37 mRNA CTD PMID:28801915 N-methyl-4-phenylpyridinium increases methylation EXP 6480464 1-Methyl-4-phenylpyridinium results in increased methylation of ANKRD37 gene CTD PMID:28801915 nickel dichloride increases expression ISO RGD:1604164 6480464 nickel chloride results in increased expression of ANKRD37 mRNA CTD PMID:21455298 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of ANKRD37 mRNA CTD PMID:22110744 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of ANKRD37 mRNA CTD PMID:26720608 ozone multiple interactions ISO RGD:1616237 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of ANKRD37 mRNA CTD PMID:34911549 p-chloromercuribenzoic acid multiple interactions ISO RGD:1604164 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ANKRD37 mRNA CTD PMID:27188386 paracetamol increases expression ISO RGD:1604164 6480464 Acetaminophen results in increased expression of ANKRD37 mRNA CTD PMID:21420995 pioglitazone multiple interactions ISO RGD:1604164 6480464 [pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ANKRD37 mRNA, pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ANKRD37 mRNA] CTD PMID:20847119 pirinixic acid multiple interactions ISO RGD:1616237 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ANKRD37 mRNA CTD PMID:19710929 pirinixic acid decreases expression ISO RGD:1616237 6480464 pirinixic acid results in decreased expression of ANKRD37 mRNA CTD PMID:23811191 quercetin decreases expression ISO RGD:1604164 6480464 Quercetin results in decreased expression of ANKRD37 mRNA CTD PMID:21632981 quinolin-8-ol decreases expression ISO RGD:1604164 6480464 Oxyquinoline results in decreased expression of ANKRD37 mRNA CTD PMID:21632981 rac-lactic acid decreases expression ISO RGD:1604164 6480464 Lactic Acid results in decreased expression of ANKRD37 mRNA CTD PMID:30851411 resorcinol increases expression ISO RGD:1604164 6480464 resorcinol results in increased expression of ANKRD37 mRNA CTD PMID:22623647 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of ANKRD37 mRNA CTD PMID:19013527 rotenone increases expression ISO RGD:1604164 6480464 Rotenone results in increased expression of ANKRD37 mRNA CTD PMID:29955902 S-(1,2-dichlorovinyl)-L-cysteine decreases expression ISO RGD:1604164 6480464 S-(1, 2-dichlorovinyl)cysteine results in decreased expression of ANKRD37 mRNA CTD PMID:33725128 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1604164 6480464 [S-(1 more ... CTD PMID:35811015 SB 431542 multiple interactions ISO RGD:1604164 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide increases expression ISO RGD:1604164 6480464 Silicon Dioxide analog results in increased expression of ANKRD37 mRNA CTD PMID:25895662 silver atom increases expression ISO RGD:1604164 6480464 Silver results in increased expression of ANKRD37 mRNA CTD PMID:26014281 silver(0) increases expression ISO RGD:1604164 6480464 Silver results in increased expression of ANKRD37 mRNA CTD PMID:26014281 sodium arsenate multiple interactions ISO RGD:1604164 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of ANKRD37 mRNA CTD PMID:32525701 sotorasib multiple interactions ISO RGD:1604164 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ANKRD37 mRNA CTD PMID:36139627 succimer multiple interactions ISO RGD:1616237 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ANKRD37 mRNA CTD PMID:21641980 sunitinib increases expression ISO RGD:1604164 6480464 Sunitinib results in increased expression of ANKRD37 mRNA CTD PMID:31533062 tert-butyl hydroperoxide multiple interactions ISO RGD:1604164 6480464 [Pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ANKRD37 mRNA more ... CTD PMID:20847119 tert-butyl hydroperoxide increases expression ISO RGD:1604164 6480464 tert-Butylhydroperoxide results in increased expression of ANKRD37 mRNA CTD PMID:20847119 testosterone increases expression ISO RGD:1604164 6480464 Testosterone results in increased expression of ANKRD37 mRNA CTD PMID:21592394 testosterone multiple interactions ISO RGD:1604164 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of ANKRD37 mRNA CTD PMID:21592394 thalidomide decreases expression ISO RGD:1616237 6480464 Thalidomide results in decreased expression of ANKRD37 mRNA CTD PMID:26217789 thimerosal decreases expression ISO RGD:1604164 6480464 Thimerosal results in decreased expression of ANKRD37 mRNA CTD PMID:27188386 titanium dioxide increases expression ISO RGD:1616237 6480464 titanium dioxide results in increased expression of ANKRD37 mRNA CTD PMID:27760801 trametinib multiple interactions ISO RGD:1604164 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ANKRD37 mRNA CTD PMID:36139627 tributylstannane increases expression EXP 6480464 tributyltin results in increased expression of ANKRD37 mRNA CTD PMID:21683754 triptonide increases expression ISO RGD:1616237 6480464 triptonide results in increased expression of ANKRD37 mRNA CTD PMID:33045310 troglitazone multiple interactions ISO RGD:1604164 6480464 [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ANKRD37 mRNA, troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ANKRD37 mRNA] CTD PMID:20847119 valproic acid decreases expression ISO RGD:1604164 6480464 Valproic Acid results in decreased expression of ANKRD37 mRNA CTD PMID:23179753 , PMID:27188386 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of ANKRD37 mRNA CTD PMID:29427782 valproic acid increases expression ISO RGD:1604164 6480464 Valproic Acid results in increased expression of ANKRD37 mRNA CTD PMID:28001369 vincristine decreases expression ISO RGD:1604164 6480464 Vincristine results in decreased expression of ANKRD37 mRNA CTD PMID:23649840 vorinostat decreases expression ISO RGD:1604164 6480464 vorinostat results in decreased expression of ANKRD37 mRNA CTD PMID:27188386 zinc atom multiple interactions ISO RGD:1604164 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of ANKRD37 mRNA CTD PMID:18593933 zinc dichloride multiple interactions ISO RGD:1604164 6480464 zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of ANKRD37 mRNA] CTD PMID:22202117 zinc(0) multiple interactions ISO RGD:1604164 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of ANKRD37 mRNA CTD PMID:18593933